Quick Answer
BIOTRICITY INC. reported Operating Income Loss of -$2.45 million for the year ending 2025.
- BIOTRICITY INC. showed an increase of +72.3% in Operating Income Loss from 2024 to 2025.
- This data is from BIOTRICITY INC.'s annual report (Form 10-K), filed with the SEC on July 15, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2021: -$4.74 million | Q2 2022: -$4.09 million | Q3 2022: -$4.03 million | Q4 2022: -$3.84 million | Q2 2023: -$2.32 million | Q3 2023: -$2.19 million | Q4 2023: -$1.28 million | Q2 2024: -$1.12 million | Q3 2024: -$307.7 thousand | Q4 2024: -$169.0 thousand | Q2 2025: $281.9 thousand | Q3 2025: $273.8 thousand | Q4 2025: $440.9 thousand.
- Over the full 4 years of available data (2022 to 2025), BIOTRICITY INC.'s Operating Income Loss has grown by 85.4%.
- Historical annual values: Fiscal year 2025: -$2.45 million | Fiscal year 2024: -$8.83 million | Fiscal year 2023: -$15.41 million | Fiscal year 2022: -$16.74 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: